OrbiMed Capital GP VIII LLC

Insider Reports History

Location
New York, NY
Signature
/s/ Carl L. Gordon, Member of OrbiMed Asia GP IV, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OrbiMed Capital GP VIII LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 550,000 $1,237,500 $2.25 17 Feb 2023 Indirect

Insider Reports Filed by OrbiMed Capital GP VIII LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000094787123000219-orbimed-capital-gp-viii-llc-2023-02-17 Kinnate Biopharma Inc. 17 Feb 2023 0 $0 3 Director, 10%+ Owner 23 Feb 2023, 12:58